LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Listă Acțiuni・Medtronic PLC

Medtronic PLC

Închisă

SectorSănătate

78.65 0.83

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

78.61

Maxim

78.91

Indicatori cheie
By Trading Economics
Venit	-231M 1.1B
Vânzări	57M 9B
P/E Medie Sector	21.598 49.701
EPS	0.89
Randament dividend	3.72
Marjă de profit	12.675
Angajați	95,000
EBITDA	124M 2.5B

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+33.44% upside

Dividende
By Dow Jones
Randament dividend Medie Sector	3.72% 2.39%
Următoarele câștiguri	3 iun. 2026
Data viitoare de dividende	10 iul. 2026
Următoarea dată ex-dividende	26 iun. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-28B 99B
Deschiderea anterioară	77.82
Închiderea anterioară	78.65

Sentimentul știrilor

By Acuity

29%

71%

60 / 345 Clasament în Healthcare

Medtronic PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

20 mai 2026, 13:49 UTC

Achiziții, Fuziuni, Preluări

Medtronic to Buy SPR Therapeutics for About $650 Million

10 mar. 2026, 11:19 UTC

Achiziții, Fuziuni, Preluări

Medtronic to Buy Scientia Vascular in $550 Million Deal

17 feb. 2026, 12:43 UTC

Câștiguri

Medtronic 3Q Profit Falls Despite Higher Revenue

20 mai 2026, 13:15 UTC

Achiziții, Fuziuni, Preluări

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20 mai 2026, 13:15 UTC

Achiziții, Fuziuni, Preluări

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22 apr. 2026, 11:27 UTC

Câștiguri

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20 apr. 2026, 11:50 UTC

Achiziții, Fuziuni, Preluări

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24 mar. 2026, 20:59 UTC

Câștiguri

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10 mar. 2026, 10:46 UTC

Achiziții, Fuziuni, Preluări

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10 mar. 2026, 10:46 UTC

Achiziții, Fuziuni, Preluări

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10 mar. 2026, 10:45 UTC

Achiziții, Fuziuni, Preluări

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10 mar. 2026, 10:45 UTC

Achiziții, Fuziuni, Preluări

Medtronic to Acquire Scientia Vascular >MDT

17 feb. 2026, 21:21 UTC

Câștiguri

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17 feb. 2026, 18:11 UTC

Câștiguri

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb. 2026, 14:48 UTC

Câștiguri

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb. 2026, 13:00 UTC

Câștiguri

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb. 2026, 12:05 UTC

Câștiguri

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb. 2026, 11:47 UTC

Câștiguri

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17 feb. 2026, 11:47 UTC

Câștiguri

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17 feb. 2026, 11:46 UTC

Câștiguri

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17 feb. 2026, 11:46 UTC

Câștiguri

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17 feb. 2026, 11:46 UTC

Câștiguri

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Adj EPS $1.36 >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Sales $9.02B >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Diabetes Rev $796M >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17 feb. 2026, 11:45 UTC

Câștiguri

Medtronic 3Q Net $1.14B >MDT

Comparație

Modificare preț

Medtronic PLC Așteptări

Obiectiv de preț

By TipRanks

33.44% sus

Prognoză pe 12 luni

Medie 104.88 USD 33.44%

Maxim 120 USD

Minim 84 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMedtronic PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

18 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 18 analiști care au acordat evaluări ale acțiunilor Medtronic PLC - Dist în ultimele 3 luni.

Sentiment

By Acuity

60 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.